Market Cap for Bristol-Myers Squibb (BMY)
According to Bristol-Myers Squibb's latest reported financial statements, the company's latest reported market cap is $110.09B USD. Market capitalization is the total dollar value of all outstanding shares — shares outstanding × stock price — and the standard measure of a company's equity value. On this page, historical market cap snaps filing-period share counts to closing prices on or before each statement date (not intraday tick data).
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
Currently viewingMarket CapSwitch metric
Latest period
$110.09B
YoY change
+6.8%
5Y CAGR
-3.4%
Peak year (2022)
$154.40B
Latest annual
$117.54B
Market Cap history chart for Bristol-Myers Squibb (BMY) from 1987 to 2026
Market Cap history table for Bristol-Myers Squibb (BMY) from 1987 to 2026
| Fiscal year | Period ended | Reported | Market Cap | YoY |
|---|---|---|---|---|
| 2026 | $117.54B | +6.8% | ||
| 2025 | $110.09B | -4.0% | ||
| 2024 | $114.65B | +7.5% | ||
| 2023 | $106.62B | -30.9% | ||
| 2022 | $154.40B | +10.3% | ||
| 2021 | $139.98B | -0.1% | ||
| 2020 | $140.06B | +27.5% | ||
| 2019 | $109.89B | +29.1% | ||
| 2018 | $85.09B | -15.9% | ||
| 2017 | $101.23B | +3.1% | ||
| 2016 | $98.18B | -15.0% | ||
| 2015 | $115.50B | +17.2% | ||
| 2014 | $98.58B | +11.6% | ||
| 2013 | $88.34B | +60.6% | ||
| 2012 | $55.01B | -9.1% | ||
| 2011 | $60.51B | +32.3% | ||
| 2010 | $45.73B | -8.4% | ||
| 2009 | $49.94B | +7.4% | ||
| 2008 | $46.52B | -11.4% | ||
| 2007 | $52.51B | +1.6% | ||
| 2006 | $51.67B | +13.4% | ||
| 2005 | $45.57B | -10.0% | ||
| 2004 | $50.63B | -9.2% | ||
| 2003 | $55.77B | +19.5% | ||
| 2002 | $46.67B | -53.4% | ||
| 2001 | $100.22B | -28.7% | ||
| 2000 | $140.59B | +13.5% | ||
| 1999 | $123.89B | -4.3% | ||
| 1998 | $129.40B | +40.7% | ||
| 1997 | $91.99B | +74.1% | ||
| 1996 | $52.83B | +27.2% | ||
| 1995 | $41.53B | +48.0% | ||
| 1994 | $28.06B | -1.9% | ||
| 1993 | $28.60B | -12.9% | ||
| 1992 | $32.84B | -24.7% | ||
| 1991 | $43.63B | +31.5% | ||
| 1990 | $33.19B | +20.0% | ||
| 1989 | $27.66B | +22.9% | ||
| 1988 | $22.51B | +6.3% | ||
| 1987 | $21.17B | — |
Market Cap values are taken from Bristol-Myers Squibb's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
In 2026, Bristol-Myers Squibb (BMY) market cap totalled $117.54B – grew 6.8% year-over-year.
Bristol-Myers Squibb market cap compound annual growth for the 2021–2026 (5 years) window is -3.4%, with a net decline across the window.
Between 2022 and 2026, Bristol-Myers Squibb market cap declined 23.9%, falling from $154.40B to $117.54B.
Across the available history, market cap reached its high of $154.40B in 2022 and its low of $21.17B in 1987.
Within Healthcare, Bristol-Myers Squibb (BMY) ranks 9th among 8 peers we track. The peer median for market cap is $311.16B.
Bristol-Myers Squibb Market Cap by Year
Bristol-Myers Squibb Market Cap 2026: $117.54B
Bristol-Myers Squibb market cap in 2026 was $117.54B, grew 6.8% from 2025.
Bristol-Myers Squibb Market Cap 2025: $110.09B
Bristol-Myers Squibb market cap in 2025 was $110.09B, edged down 4.0% below 2024.
Bristol-Myers Squibb Market Cap 2024: $114.65B
Bristol-Myers Squibb market cap in 2024 was $114.65B, grew 7.5% from 2023.
Bristol-Myers Squibb Market Cap 2023: $106.62B
Bristol-Myers Squibb market cap in 2023 was $106.62B, plunged 30.9% below 2022.
Bristol-Myers Squibb Market Cap 2022: $154.40B
Bristol-Myers Squibb market cap in 2022 was $154.40B.
See more financial history for Bristol-Myers Squibb (BMY).
Sector peers — Market Cap
Companies in the same sector as Bristol-Myers Squibb, ranked by their latest market cap.
| Company | Market Cap | Sector |
|---|---|---|
| Eli Lilly and Company (LLY) | $825.77B | Healthcare |
| Johnson & Johnson (JNJ) | $548.34B | Healthcare |
| AbbVie Inc. (ABBV) | $349.67B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $332.91B | Healthcare |
| AstraZeneca PLC (AZN) | $289.41B | Healthcare |
| Merck & Co., Inc. (MRK) | $272.11B | Healthcare |
| Amgen Inc. (AMGN) | $183.05B | Healthcare |
| Novo Nordisk A/S (NVO) | $182.96B | Healthcare |
Frequently asked questions
What is Bristol-Myers Squibb's market cap?
- Latest reported market cap for Bristol-Myers Squibb (BMY) is $110.09B (period ending December 31, 2025).
How has Bristol-Myers Squibb market cap changed year-over-year?
- Bristol-Myers Squibb (BMY) market cap changed +6.8% year-over-year on the latest annual filing.
What is the long-term growth rate of Bristol-Myers Squibb market cap?
- Bristol-Myers Squibb (BMY) market cap compound annual growth rate is -3.4% over the most recent 5 years available.
When did Bristol-Myers Squibb market cap hit its highest annual value?
- Bristol-Myers Squibb market cap reached its highest annual value of $154.40B in 2022.
What was Bristol-Myers Squibb market cap in 2025?
- Bristol-Myers Squibb (BMY) market cap in 2025 was $110.09B.
What was Bristol-Myers Squibb market cap in 2026?
- Bristol-Myers Squibb (BMY) market cap in 2026 was $117.54B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
BMY Overview
Company profile, financial tools, and key metrics
BMY Revenue Counter
Earns $1,528 every second. See per minute, hour, and day.
BMY Earnings Counter
Earns $223.65 per second net profit. See per minute, hour, and day.
BMY Economic Scale
Exceeds Bahrain's GDP. Compare with world economies.
BMY What If Invested
What if you had invested $1,000? See historical returns from any date.
BMY How It Makes Money
Discover visual breakdown of $48.19B in revenue — where it comes from and where it goes.
BMY Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
BMY Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
BMY Daily Price Character
Steady · 47.3% historical win rate (green days). Streaks & record days.
BMY Buybacks
Recent repurchase activity. Shareholder yield & SBC comparison.
BMY Stock Split History
6 splits on record. Dates, ratios, and cumulative multiple.
BMY Dividend Profile
Yield: 4.34%. Safety: 7/8. See full history.
BMY Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
BMY Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.